Filtros de búsqueda

Lista de obras de Bruno Coudert

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.

artículo científico publicado en 2013

A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: a French anticancer federation study

scientific article published on 01 November 1999

A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971.

artículo científico publicado en 2008

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

artículo científico publicado en 2017

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial

artículo científico publicado en 2015

Age and prognosis of non-small cell lung cancer. Usefulness of a relative survival model

artículo científico publicado en 1993

Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.

artículo científico publicado en 2017

Amiodarone is more efficient than verapamil in reversing resistance to anthracyclines in tumour cells

artículo científico publicado en 1987

Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature

artículo científico publicado en 1992

Angiogenesis targeting in breast cancer

artículo científico publicado en 2007

Antibiotic Use Does Not Appear to Influence Response to Nivolumab

artículo científico publicado en 2017

Association between lung cancer somatic mutations and occupational exposure in never-smokers

artículo científico publicado en 2017

Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer

artículo científico publicado en 2011

BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers

artículo científico publicado en 2015

Bone metastases from a melanoma of the anal verge

artículo científico publicado en 1998

Breast cancer screening: On our way to the future

artículo científico publicado en 2016

Brown adipose tissue activity in relation to weight gain during chemotherapy in breast cancer patients: a pilot study.

artículo científico publicado en 2014

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

artículo científico publicado en 2007

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

artículo científico publicado en 2008

Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes

scientific article published on 12 April 2012

Changing practice in systemic breast cancer adjuvant treatment in a well-defined French population

artículo científico publicado en 1999

Circadian concepts in normal and neoplastic breast

artículo científico publicado en 2002

Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer

artículo científico publicado en 2009

Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01).

artículo científico publicado en 2003

Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiography

artículo científico publicado en 1998

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3.

artículo científico publicado en 2011

Cost/effectiveness analysis of adjuvant therapy with trastuzumab in patients with HER2 positive early breast cancer

artículo científico publicado en 2007

Determining factors for adjuvant treatment of breast cancer in the Côte d'Or region 1982-1990. Registry of gynecologic cancers at the Côte d'Or

artículo científico publicado en 1996

Diagnostic and predictive value of skin testing in platinum salt hypersensitivity

scientific article published on 25 January 2007

Diagnostic value of broncho-alveolar lavage in lung diseases caused by amiodarone

artículo científico publicado en 1989

Diastolic or systolic left and right ventricular impairment at moderate doses of anthracycline? A 1-year follow-up study of women

artículo científico publicado en 1996

Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone

artículo científico publicado en 2015

Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors

artículo científico publicado en 2012

Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer Patients

artículo científico publicado en 2018

Extended benefit from sequential administration of docetaxel after standard fluorouracil, epirubicin, and cyclophosphamide regimen for node-positive breast cancer: the 8-year follow-up results of the UNICANCER-PACS01 trial

artículo científico publicado en 2012

Feasibility and safety of weekly sequential epirubicin-paclitaxel as adjuvant treatment for operable breast cancer patients older than 70 years.

artículo científico publicado en 2011

Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis

artículo científico publicado en 2006

Gene expression profile and response to trastuzumab-docetaxel-based treatment in breast carcinoma.

scientific article published on 15 September 2009

Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer.

artículo científico publicado en 1999

HER2-positive breast cancer: ¹⁸F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy

artículo científico publicado en 2014

HER2-positivity rates in breast cancer: no variation over time when clinicopathological features and testing are stable

artículo científico publicado en 2015

Hepatic arterial infusion of cisplatin diluted in hypotonic 25 g/l glucose solution administered in balloon-occluded hepatic artery: experimental rationale and clinical pilot study.

artículo científico publicado en 2001

Immunophenotype in erythroleukemia secondary to myelodysplastic syndrome

scientific article published on 01 August 1992

Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based study

artículo científico publicado en 2013

Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).

artículo científico publicado en 2012

Impairment of diastolic function during short-term anthracycline chemotherapy

artículo científico publicado en 1995

In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival

artículo científico publicado en 2011

Is immunohistochemistry less sensitive than quantitative reverse transcriptase polymerase chain reaction for hormone receptor status determination in breast cancer?

artículo científico publicado en 2009

It is time for chronotherapy!

artículo científico publicado en 2003

It's time for chronotherapy!

artículo científico publicado en 2002

Ixabepilone Alone or With Cetuximab as First-Line Treatment for Advanced/Metastatic Triple-Negative Breast Cancer

scientific article published on 15 August 2014

Long-term follow-up of HER2-overexpressing stage II or III breast cancer treated by anthracycline-free neoadjuvant chemotherapy.

artículo científico publicado en 2010

Long-term recurrence of secretory breast carcinoma with metastatic sentinel lymph nodes

scientific article published on 14 September 2010

MDR1 and thymidylate synthase (TS) gene expressions in advanced breast cancer: relationships to drug exposure, p53 mutations, and clinical outcome of the patients

scientific article published on 01 July 1999

Management of metastatic HER2-positive breast cancer: present and future

artículo científico publicado en 2010

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer.

artículo científico publicado en 2003

Metabolic activation of 4-ipomeanol in human lung, primary pulmonary carcinomas, and established human pulmonary carcinoma cell lines

artículo científico publicado en 1990

Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2–Overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 Trial

artículo científico publicado en 2007

Multifocal malignant fibrous histiocytoma of the spine

scientific article published on 01 April 1997

Neoadjuvant chemotherapy FEC-HD in locally advanced breast cancer

artículo científico publicado en 1999

Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matching

artículo científico publicado en 2012

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

artículo científico publicado en 2017

Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations.

artículo científico publicado en 2014

Nilutamide pneumonitis: a report on eight patients

artículo científico publicado en 1992

Nitrosourea-induced lung diseases

scientific article published on 01 January 1992

Nivolumab versus docetaxel in previously treated advanced non-small cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

artículo científico publicado en 2018

No impact of passive smoke on the somatic profile of lung cancers in never-smokers

artículo científico publicado en 2015

Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues

artículo científico publicado en 2007

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

artículo científico publicado en 2016

Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells

artículo científico publicado en 2008

Pathologic complete response to trastuzumab-based neoadjuvant therapy is related to the level of HER-2 amplification

artículo científico publicado en 2007

Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer

artículo científico publicado en 2010

Pathological response and survival after neoadjuvant therapy for breast cancer: a 30-year study

artículo científico publicado en 2012

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer

artículo científico publicado en 2012

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

artículo científico publicado en 2015

Pharmacokinetics and metabolism of nilutamide in the isolated rat lung

artículo científico publicado en 1991

Pharmacokinetics of amiodarone in the isolated rat lung

artículo científico publicado en 1990

Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer

artículo científico publicado en 2003

Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme

artículo científico publicado en 2002

Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study

artículo científico publicado en 2008

Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer

artículo científico publicado en 2002

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

artículo científico publicado en 2001

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

artículo científico publicado en 2000

Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment

scientific article published on 01 August 2006

Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC-FFCD 9710.

artículo científico publicado en 2009

Pneumopathy caused by methotrexate

artículo científico publicado en 1990

Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial

artículo científico publicado en 2005

Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer.

artículo científico publicado en 2012

Predictive Factors of Response in HER2-Positive Breast Cancer Treated by Neoadjuvant Therapy

artículo científico publicado en 2013

Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis

artículo científico publicado en 2016

Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy

artículo científico publicado en 2010

Prognostic role of pregnancy occurring before or after treatment of early breast cancer patients aged <35 years: a GET(N)A Working Group analysis.

artículo científico publicado en 2009

Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients

artículo científico publicado en 2001

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†.

artículo científico publicado en 2015

Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer

artículo científico publicado en 2017

Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancer

scientific article published on 14 August 2007

Role of positron emission tomography for the monitoring of response to therapy in breast cancer

artículo científico publicado en 2015

Sensitivity and specificity of thallium-201 scintigraphy for the diagnosis of malignant vertebral fractures

artículo científico publicado en 2004

Sequential addition of an anthracycline-based regimen to docetaxel as neoadjuvant chemotherapy in patients with operable breast cancer

scientific article published on 01 August 2006

Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study.

artículo científico publicado en 2005

Serum concentrations of amiodarone required for an in vivo modulation of anthracycline resistance

artículo científico publicado en 1989

Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis.

artículo científico publicado en 2012

Spontaneous pyopneumothorax in patients treated with mTOR inhibitors for subpleural pulmonary metastases

artículo científico publicado en 2009

Subcutaneous interleukin-2 and interferon alpha in the treatment of patients with metastatic renal cell carcinoma-Less efficacy compared with intravenous interleukin-2 and interferon alpha. Results of a multicenter Phase II trial from the Groupe Fra

artículo científico publicado en 2002

Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy.

artículo científico publicado en 2011

T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival

artículo científico publicado en 2011

Targeting ErbB receptors in breast cancer

artículo científico publicado en 2007

Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy.

artículo científico publicado en 2015

Trastuzumab for patients with axillary-node-positive breast cancer: results of the FNCLCC-PACS 04 trial

artículo científico publicado en 2009

Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?

artículo científico publicado en 2006

Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational study

artículo científico publicado en 2013

Types of interaction of amphiphilic drugs with phospholipid vesicles

artículo científico publicado en 1988

Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATA

artículo científico publicado en 2014

Use of dedicated gene panel sequencing using next generation sequencing to improve the personalized care of lung cancer

artículo científico publicado en 2016

Variations in gene expression and response to neoadjuvant chemotherapy in breast carcinoma.

artículo científico publicado en 2009

[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy

artículo científico publicado en 2007

[Appropriate cytotoxic drug usages in solid tumors: conformity to official labelling and level of scientific evidence]

scientific article published on 01 October 2006

[Chloroquine poisoning. Apropos of severe poisoning]

artículo científico publicado en 1987

[Clinical Practice guidelines for the use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin bêta, darbepoetin) in anaemic patients with cancer: 2007 update (summary report)]

artículo científico publicado en 2008

[Clinical value of the estimation of growth kinetics of primary ovarian cancer recurrences by CA125 doubling time]

artículo científico publicado en 1997

[Comparison of relative survival vs. classical survival. Apropos of primary bronchial cancer]

scientific article published on 01 October 1994

[Congenital paravertebral arteriovenous fistulae in children and adolescents]

scientific article published on 01 May 1986

[Drug-induced respiratory complications. Study of 27 cases]

artículo científico publicado en 1989

[Erratum to: "Breast cancer screening: On our way to the future" [Bull. Cancer 103 (2016) 753-763]]

artículo científico publicado en 2016

[Feasability of the dose adjustment of continuous infusion administration over 120 hours of 5-fluorouracil associated with cisplatin]

artículo científico publicado en 1996

[Hypoglycemia during a treatment with interferon-alpha]

scientific article published on 01 May 1997

[Interpretation of the CA125 kinetics during first line chemotherapy of the ovarian cancer: methodological aspects and characteristic profiles]

artículo científico publicado en 2002

[Non small-cell bronchial cancer]

scientific article published on 01 January 1994

[Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma]

artículo científico publicado en 2000

[Poor prognostic value of weight change during chemotherapy in non-metastatic breast cancer patients: causes, mechanisms involved and preventive strategies]

artículo científico publicado en 2013

[Prognostic value of CA 125 initial half-life measured during first-line chemotherapy in 62 patients with epithelial ovarian cancer stage III or IV]

artículo científico publicado en 1996

[Pulmonary edema with low pulmonary capillary pressure in cardiogenic shock treated successfully by volume replacement: 2 cases]

artículo científico publicado en 1986

[Reflections on the management of suspected recent pulmonary embolism]

artículo científico publicado en 1991

[Respiratory manifestations of hemorrhagic rectocolitis]

artículo científico publicado en 1991

[The anti-tumor immune response in breast cancer: Update and therapeutic perspectives].

artículo científico publicado en 2017

[Tricuspid endocarditis with right-left auricular shunt through a patent foramen ovale]

artículo científico publicado en 1987

[Tuberculous abscess of the psoas muscle without spinal involvement]

scientific article published on 01 May 1986

[Yellow nail syndrome. A new etiology of restrictive respiratory insufficiency?]

artículo científico publicado en 1982

p53 gene alterations are associated with a decreased responsiveness to neoadjuvant chemotherapy in human breast cancer

artículo científico publicado en 1997

¹⁸F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations

artículo científico publicado en 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda